DE3372066D1 - Pharmaceutical preparation for endermic use - Google Patents

Pharmaceutical preparation for endermic use

Info

Publication number
DE3372066D1
DE3372066D1 DE8383302348T DE3372066T DE3372066D1 DE 3372066 D1 DE3372066 D1 DE 3372066D1 DE 8383302348 T DE8383302348 T DE 8383302348T DE 3372066 T DE3372066 T DE 3372066T DE 3372066 D1 DE3372066 D1 DE 3372066D1
Authority
DE
Germany
Prior art keywords
endermic
pharmaceutical preparation
pharmaceutical
preparation
endermic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383302348T
Other languages
German (de)
English (en)
Inventor
Toshio Inagi
Masayuki Inoue
Toyojiro Muramatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Application granted granted Critical
Publication of DE3372066D1 publication Critical patent/DE3372066D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8383302348T 1982-04-30 1983-04-26 Pharmaceutical preparation for endermic use Expired DE3372066D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57072959A JPS58189115A (ja) 1982-04-30 1982-04-30 外用剤

Publications (1)

Publication Number Publication Date
DE3372066D1 true DE3372066D1 (en) 1987-07-23

Family

ID=13504421

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383302348T Expired DE3372066D1 (en) 1982-04-30 1983-04-26 Pharmaceutical preparation for endermic use

Country Status (5)

Country Link
US (1) US4474798A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0093563B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS58189115A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1194801A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3372066D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931283A (en) * 1983-12-22 1990-06-05 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
AU6656886A (en) * 1985-12-16 1987-06-18 Cilag A.G. Pharmaceutical composition of suprofen
JPH07106979B2 (ja) * 1988-05-27 1995-11-15 久光製薬株式会社 経皮投与製剤
JP2905210B2 (ja) * 1989-01-23 1999-06-14 フロイント産業株式会社 経皮、経粘膜吸収促進剤および経皮、経粘膜製剤
US5164416A (en) * 1989-02-03 1992-11-17 Lintec Corporation Transdermal therapeutic formulation containing a limonene
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
WO1991015241A1 (en) * 1990-03-30 1991-10-17 Yasunori Morimoto Percutaneously absorbable composition of narcotic and nonnarcotic analgesics
EP0680256A1 (en) * 1993-01-25 1995-11-08 Pmc Specialties Group, Inc. Solid bird aversion compositions
US5869087A (en) * 1994-09-16 1999-02-09 Hisamitsu Pharmaceutical Co., Inc. Patch having a preparation for external use attached thereto
FR2739032B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique
JPH11171768A (ja) * 1997-10-15 1999-06-29 Taisho Pharmaceut Co Ltd 消炎鎮痛外用剤
US6818049B1 (en) 1998-05-05 2004-11-16 Exxonmobil Chemical Patents Inc. Environmentally preferred fluids and fluid blends
US6280519B1 (en) 1998-05-05 2001-08-28 Exxon Chemical Patents Inc. Environmentally preferred fluids and fluid blends
US7553865B2 (en) * 2002-07-29 2009-06-30 Kowa Company, Ltd. Indomethacin external preparation
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
WO2004089357A2 (en) * 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil
US7597913B2 (en) 2004-10-04 2009-10-06 Marc Selner Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes
JP4824343B2 (ja) * 2005-05-30 2011-11-30 興和株式会社 消炎鎮痛外用剤
JP2008239497A (ja) * 2007-03-23 2008-10-09 Lintec Corp 消炎鎮痛貼付剤
JPWO2009031318A1 (ja) * 2007-09-05 2010-12-09 興和株式会社 鎮痛・抗炎症剤含有外用剤
US8501247B2 (en) 2008-03-19 2013-08-06 Tyratech, Inc. Pest control using natural pest control agent blends
JP5844260B2 (ja) 2009-09-24 2016-01-13 ユニリーバー・ナームローゼ・ベンノートシヤープ オイゲノール、テルピネオールおよびチモールを含む殺菌剤
CN103354741B (zh) 2010-12-07 2016-01-13 荷兰联合利华有限公司 口腔护理组合物
CN102908441B (zh) * 2011-08-02 2014-07-16 北京中医药大学 一种用于止痛的微乳型药物组合物凝胶膏剂及其制备方法
KR102180667B1 (ko) * 2011-09-29 2020-11-20 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
IN2014MN00808A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2011-11-03 2015-09-04 Unilever Plc
CN103099892B (zh) * 2013-01-09 2015-04-29 张大雷 一种治疗关节痛、肌肉痛的膏药
DE102013020633A1 (de) * 2013-12-16 2015-06-18 Epinamics Gmbh Dermale und/oder transdermale pharmazeutische Zusammensetzung enthaltend eine terpenoide Verbindung
KR20220158031A (ko) 2020-03-26 2022-11-29 피엘엑스 옵코 인코포레이티드 pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281225A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1961-07-20
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments
JPS5562013A (en) * 1978-11-02 1980-05-10 Rakuule Yakuhin Hanbai Kk Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent
JPS5735509A (en) * 1980-08-12 1982-02-26 Grelan Pharmaceut Co Ltd Analgesic and antiphlogistic cream
JPS5762221A (en) * 1980-10-02 1982-04-15 Lion Corp Embrocation for external use
JPS5798209A (en) * 1980-12-09 1982-06-18 Kowa Co Remedy for dermatopathy for external use

Also Published As

Publication number Publication date
CA1194801A (en) 1985-10-08
EP0093563B1 (en) 1987-06-16
US4474798A (en) 1984-10-02
JPH0345044B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-07-09
JPS58189115A (ja) 1983-11-04
EP0093563A3 (en) 1984-09-12
EP0093563A2 (en) 1983-11-09

Similar Documents

Publication Publication Date Title
DE3372066D1 (en) Pharmaceutical preparation for endermic use
GB8327748D0 (en) Medicinal preparation
ZW15983A1 (en) New pharmaceutical preparations
DE3376957D1 (en) Pharmaceutical gel composition
GB8313530D0 (en) Pharmaceutical preparations
ZA848375B (en) Medicament formulation
DE3378523D1 (en) Pharmaceutical formulations
GB8414688D0 (en) Pharmaceutical preparation
GB8411259D0 (en) Medicinal agent
GB8321595D0 (en) Pharmaceutical preparations
ZA834074B (en) Pharmaceutical composition
GB8418367D0 (en) Medicinal preparation
MY8700292A (en) Pharmaceutical mixture
DE3264782D1 (en) Medicinal formulation
EP0093551A3 (en) Pharmaceutical composition
ZA84856B (en) New pharmaceutical preparation
GB8413576D0 (en) Pharmaceutical preparation
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
GB8332269D0 (en) Pharmaceutical compounds
GB8328896D0 (en) Pharmaceutical composition
GB8403257D0 (en) Medicinal preparation
GB8410363D0 (en) Pharmaceutical preparation
GB8422453D0 (en) Pharmaceutical formulation
GB8332653D0 (en) Pharmaceutical composition
ZA833506B (en) Pharmaceutical preparations

Legal Events

Date Code Title Description
8364 No opposition during term of opposition